Xinwei Medical-B (06609) Fa Yingxi expects adjusted net profit of not less than 70 million yuan in the first half of the year to increase by at least 104.7% year-on-year

Zhitong Finance App News, Xinwei Medical-B (06609) announced that the group expects to achieve revenue of no less than 280 million yuan in the first half of 2026, an increase of at least 50.9%; net profit of not less than 60 million yuan, net profit of 50.9 million yuan for the same period in 2025; adjusted net profit of not less than 70 million yuan, an increase of at least 104.7% year on year.

According to the announcement, the increase in expected performance is mainly due to the fact that the Group's products are more widely recognized by customer groups, thereby driving the continued growth in end user demand; the Group's business coverage of hospitals was further expanded during the reporting period; and the rapid increase in revenue for the three core businesses (ischemic stroke, hemorrhagic stroke, and vascular closure). The increase in adjusted net profit was mainly due to an increase in the revenue contribution of high-margin products, which led to an increase in overall gross margin compared to the same period last year; as well as improvements in operating efficiency, sales and distribution expenses and administrative expenses were effectively controlled.